On November 5, JD HEALTH recorded an Intraday Rise of 3.99% in Regular Trading, trading at HK$42.16, with turnover of HK$43.32 million.
The move coincided with broad strength in Hong Kong-listed health e-commerce and large internet names. Recent market updates showed peers including ALI HEALTH and PA GOODDOCTOR also rising, while major platform stocks across the sector advanced, providing sector-linkage support to JD HEALTH shares.
Fundamentally, the company reported first-half revenue of RMB409 billion, up 15.9% year over year, while Non-IFRS operating profit reached RMB35 billion, up 40.3%, with operating margin improving to 8.5%. A recent monthly filing also indicated its share capital structure remained stable, with no material share issuance or buyback.
(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)
Comments